Bioretec Ltd Financial calendar 24 March 2026 at 1:45 p.m. EET

TAMPERE, Finland, March 24, 2026 /PRNewswire/ -- Bioretec Ltd publishes its January-March 2026 Business Review on 15 May 2026. The earlier announced publication date was 14 May 2026.

For additional information:
Sarah van Hellenberg Hubar-Fisher, CEO
+31 6 1544 8736
sarah.hubar-fisher@bioretec.com

Tuukka Paavola, CFO
+358 50 386 0013
tuukka.paavola@bioretec.com

Certified adviser
Nordic Certified Adviser AB, +46 70 551 67 29

Information about Bioretec

Bioretec is a globally operating Finnish medical device pioneer at the forefront of transforming orthopedic care with fully biodegradable implant technologies. The company has built unique competencies in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and manufactured by Bioretec are used worldwide in approximately 40 countries.

The company's latest innovation, the RemeOs™ product line, is based on a high-performance magnesium alloy and hybrid composite, introducing a new generation of strong absorbable materials for enhanced surgical outcomes. The RemeOs implants are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The first RemeOs product market authorization was received in the U.S. in March 2023, and in Europe, the CE mark approval was received in January 2025.

Bioretec's Activa product line features fully bioabsorbable orthopedic implants made from a proprietary, self-reinforced PLGA both CE marked and FDA cleared for a wide range of indications in adult and pediatric patients.

Bioretec is shaping the future of orthopedic treatment with a focus on healing through absorption, paving the way for more effective and patient-friendly solutions.

To learn more about Bioretec, visit www.bioretec.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/bioretec/r/change-to-the-publication-date-of-business-review--bioretec-publishes-january-march-2026-business-re,c4325835

View original content:https://www.prnewswire.co.uk/news-releases/change-to-the-publication-date-of-business-review-bioretec-publishes-january-march-2026-business-review-on-15-may-2026-302723343.html

Tags

More Like This

Bioretec Ltd's financial statements bulletin for January-December 2025 will be published on February 13, 2026

Bioretec Ltd's schedule for financial reporting in 2024 and updates in the disclosure policy

Bioretec Ltd's Annual Report 2024 published

Bioretec Ltd's schedule for financial reporting and Annual General Meeting in 2026

Bioretec Ltd's business review January-March 2024: Controlled launch in the U.S. progresses

Bioretec Ltd's Financial Statements and Annual Report 2025 published

A year of rebuilding and renewed focus

Bioretec Ltd's business review January-September 2025: Strengthening commercial foundations and strategy design